EMA Authorised: Prasugrel Viatris (previously Prasugrel Mylan) (prasugrel besilate) — Viatris Limited

View source ↗

Summary

EMA authorised Prasugrel Viatris (prasugrel besilate) by Viatris Limited; the product is approved for myocardial infarction, acute coronary syndrome, and unstab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Unstable Angina

Drugs mentioned

• Prasugrel Viatris (prasugrel)

Snippet

Status: Authorised. Therapeutic area: Myocardial Infarction;Acute Coronary Syndrome;Angina, Unstable. MAH: Viatris Limited. Decision date: 22/09/2025